These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects. Płatek T; Polus A; Góralska J; Raźny U; Dziewońska A; Micek A; Dembińska-Kieć A; Solnica B; Malczewska-Malec M Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33670024 [TBL] [Abstract][Full Text] [Related]
49. The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in a Chinese population with normal glucose tolerance. Jiang S; Zhang R; Li H; Fang Q; Jiang F; Hou X; Hu C; Jia W J Nutrigenet Nutrigenomics; 2014; 7(3):121-9. PubMed ID: 25359230 [TBL] [Abstract][Full Text] [Related]
50. Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals. Son JW; Kim MK; Park YM; Baek KH; Yoo SJ; Song KH; Son HS; Yoon KH; Lee WC; Cha BY; Son HY; Kwon HS Endocr J; 2011; 58(1):39-46. PubMed ID: 21186333 [TBL] [Abstract][Full Text] [Related]
51. Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis. Takebe N; Hasegawa Y; Matsushita Y; Chiba H; Onodera K; Kinno H; Oda T; Nagasawa K; Segawa T; Takahashi Y; Okada K; Ishigaki Y Medicine (Baltimore); 2023 Sep; 102(35):e34797. PubMed ID: 37657012 [TBL] [Abstract][Full Text] [Related]
52. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes. Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320 [TBL] [Abstract][Full Text] [Related]
53. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: The BCAMS Study. Li G; Yin J; Fu J; Li L; Grant SFA; Li C; Li M; Mi J; Li M; Gao S Diabetes Metab; 2017 Jun; 43(3):253-260. PubMed ID: 28139438 [TBL] [Abstract][Full Text] [Related]
54. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes. Barb D; Bril F; Kalavalapalli S; Cusi K J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827 [TBL] [Abstract][Full Text] [Related]
56. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome. Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Krsek M; Haluzík M Physiol Res; 2010; 59(3):415-422. PubMed ID: 19681655 [TBL] [Abstract][Full Text] [Related]
57. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content. Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744 [TBL] [Abstract][Full Text] [Related]
58. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques. An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928 [TBL] [Abstract][Full Text] [Related]
59. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat. Li H; Wu G; Fang Q; Zhang M; Hui X; Sheng B; Wu L; Bao Y; Li P; Xu A; Jia W Nat Commun; 2018 Jan; 9(1):272. PubMed ID: 29348470 [TBL] [Abstract][Full Text] [Related]
60. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. Li X; Wu X; Jia Y; Fu J; Zhang L; Jiang T; Liu J; Wang G J Diabetes Res; 2021; 2021():3715026. PubMed ID: 34660809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]